Senior Director, Biologics R&D

Smith+Nephew•Columbia, MD
•Hybrid

About The Position

The Senior Director, Biologics R&D is accountable for integrating and delivering a strategic biologics development program at Smith+Nephew. The role turns enterprise strategy into an executable global development plan and leads a cross-functional team spanning Clinical, Medical, Regulatory, CMC, Quality, Nonclinical, Finance, Legal, external manufacturing partners and specialist consultants. It owns program delivery, governance, budget, timeline, risks and decision quality, while functional leaders retain authority for professional standards, regulated decisions and technical deliverables. The role does not replace the Medical Monitor or Regulatory, Quality or functional CMC authorities; it provides integrated leadership across the program. The position leads the assigned program through its approved scope and prepares evidence-based recommendations for future investment gates. It owns the integrated strategy and roadmap from early clinical development through Phase 2 readiness, pivotal-development planning, registration readiness and lifecycle options, subject to governance approval. This includes integrating functional strategies into a baselined plan with assumptions, dependencies, decision gates and contingency paths; leading matrixed internal and external contributors; managing program budgets and resources with Finance; and communicating recommendations and material risks to executive governance. The Senior Director oversees clinical and medical integration in partnership with qualified medical and clinical leaders, without superseding their authority. The role coordinates study strategy and execution, safety and enrollment oversight, data quality, evidence gaps and readiness criteria. It also integrates CMC, manufacturing and supply planning, including technology transfer, process and analytical knowledge, comparability, stability, specifications, clinical supply, second-source options and registration readiness. It coordinates technical stewards and external manufacturers and works to preserve Smith+Nephew's access to data, methods, process know-how and future transfer options. The role partners with Regulatory and Quality on health-authority engagement, commitments, submission planning, development quality systems, vendor qualification, audits, CAPA and inspection readiness. It progressively builds registration readiness through traceable decisions and controlled documentation. Governance responsibilities include leading weekly operating reviews and monthly executive governance materials, maintaining risk and decision registers and milestone baselines, managing financial forecasts and communicating evidence-based recommendations and escalations. The Senior Director builds and mentors a high-performing matrix team, clarifies decision rights and accountability, develops internal biologics-development capability, and recommends the appropriate balance of employees, shared functions and external expertise. The work is guided by patient focus, scientific rigor, quality, constructive challenge, accountability and timely escalation.

Requirements

  • Advanced degree in a life-science, pharmaceutical, engineering, medical or related discipline; a PhD, PharmD, MD or equivalent advanced scientific degree is preferred.
  • Substantial experience in pharmaceutical or biotechnology product development, including direct leadership of biologic or therapeutic programs in a regulated environment.
  • Demonstrated experience leading cross-functional development teams across Clinical, Regulatory, CMC/Technical Operations, Quality and external partners.
  • Experience progressing at least one drug or biologic program through major development and regulatory milestones.
  • Working knowledge of IND development, GCP, GMP, biologics CMC, technology transfer, CDMO governance, clinical supply and health-authority interactions.
  • Demonstrated ownership of budgets, integrated timelines, risk management, governance and executive decision support.
  • Experience operating in a global corporate matrix and influencing senior functional leaders without relying solely on line authority.
  • Excellent written and verbal communication, including the ability to explain complex scientific and operational issues to executives and technical teams.
  • Enterprise accountability: act for the program and company rather than a single function.
  • Strategic judgment: distinguish facts, assumptions and unresolved evidence and make risk-balanced recommendations.
  • Execution discipline: translate strategy into owners, milestones, budgets and closure criteria.
  • Matrix leadership: create alignment across independent functions and external partners.
  • Courage and transparency: escalate risks early, challenge constructively and avoid false certainty.
  • Talent and capability building: internalize knowledge and develop sustainable teams.
  • Patient and quality focus: center participant safety, product quality and regulatory integrity in decisions.

Nice To Haves

  • Direct Phase 2/3 and marketing-application experience.
  • Experience with topical biologics, enzymes, wound care, dermatology, burns, regenerative medicine or locally acting therapies.
  • Technology-transfer experience involving microbial fermentation, protein or enzyme drug substance and topical drug product.
  • Experience with external manufacturing and CDMO partnerships, including comparability, validation, audits and inspection readiness.
  • Experience with government-funded or military clinical-development collaborations.
  • Experience transitioning a consultant-heavy or virtual biotechnology program into a larger corporate operating model.
  • Commercial, market-access or portfolio exposure sufficient to connect development choices to value creation and lifecycle strategy.
  • PhD, PharmD, MD or equivalent advanced scientific degree.

Responsibilities

  • Lead the assigned biologics development program within its approved scope and prepare evidence-based recommendations for subsequent investment gates.
  • Own the integrated development strategy and roadmap from early clinical development through Phase 2 readiness, pivotal-development planning, registration readiness and lifecycle options, subject to governance approval.
  • Integrate Clinical, Medical, Regulatory, CMC, Quality and Nonclinical strategies into a baselined plan with assumptions, dependencies, decision gates and contingency paths.
  • Lead matrixed internal teams and external consultants, CROs, laboratories, collaborators and CDMOs.
  • Own program-level budgets, forecasts, resource plans, scenarios and cost discipline in partnership with Finance.
  • Provide recommendations to executive governance and promptly escalate material safety, compliance, supply, regulatory, funding and schedule risks.
  • Establish knowledge-transfer, documentation and exit requirements for critical external roles so consultants supplement rather than own company decisions.
  • Develop, maintain and execute the integrated development plan, milestones, critical path and risk-adjusted scenarios.
  • Lead cross-functional assessment of clinical sequence, indication priorities, evidence needs, manufacturing readiness and regulatory strategy.
  • Translate scientific, clinical and operational information into recommendations, trade-offs and investment decisions aligned with the target product profile, patient needs, intended claims, competitive context and value proposition.
  • Partner with Medical and Clinical leadership on medical monitoring, participant-safety oversight, protocol strategy, dose and regimen decisions, and clinical-operational readiness.
  • Convert early clinical outputs and evidence gaps into explicit Phase 2 entry criteria and regulatory questions.
  • Coordinate Clinical Operations, Biostatistics, Data Management and external study partners to align study execution, data quality and decision timelines.
  • Maintain program oversight of safety, enrollment, product availability, study dependencies and inspection-ready documentation without superseding medical or clinical authority.
  • Lead integrated governance of drug-substance and drug-product technology transfer and its contractual, technical, quality, regulatory, supply and budget dependencies.
  • Ensure the CMC plan addresses process knowledge, analytical methods, comparability, stability, specifications, control strategy, clinical supply, second-source optionality and registration readiness.
  • Coordinate internal technical stewards, Quality, Regulatory, Legal and external manufacturing partners against shared stage gates and acceptance criteria.
  • Ensure agreements and execution plans preserve Smith+Nephew's access to data, methods, process know-how and future transfer options.
  • Partner with Regulatory on health-authority engagement, regulatory commitments, CMC impact assessments, submission roadmap and registration-readiness strategy.
  • Partner with Quality on development quality systems, vendor qualification, quality agreements, audit readiness, deviation and CAPA governance, data integrity and inspection readiness.
  • Build registration readiness through traceable decisions, controlled source documentation, submission-quality evidence and actively managed gaps.
  • Support transition from consultant-led continuity to durable internal Regulatory and Quality capability.
  • Prepare and lead weekly operating reviews and monthly executive governance materials, decisions, action logs and escalation follow-up.
  • Own the integrated risk register, decision register, milestone baseline, resource assumptions and executive dashboard.
  • Partner with Finance on budgets, forecasts, capital versus OpEx inputs, commitments, contingencies and scenario-based funding requirements.
  • Communicate progress, constraints, changes and recommendations clearly, transparently and with appropriate evidence.
  • Build a high-performing matrix team with clear role charters, decision rights, interfaces and accountability.
  • Mentor contributors and develop internal biologics-development capability across functions.
  • Recommend an appropriate mix of permanent employees, shared functions and targeted external expertise.
  • Foster patient focus, scientific rigor, quality, constructive challenge, accountability and timely escalation.

Benefits

  • 401k Matching Program
  • 401k Plus Program
  • Discounted Stock Options
  • Tuition Reimbursement
  • Flexible Personal/Vacation Time Off
  • Paid Holidays
  • Flex Holidays
  • Paid Community Service Day
  • Medical
  • Dental
  • Vision
  • Health Savings Account with employer contribution of $500+ annually
  • Employee Assistance Program
  • Parental Leave
  • Fertility and Adoption Assistance Program
  • Hybrid work model for most professional roles
  • Hands-on, team-customized training and mentorship
  • Discounts on fitness clubs, travel and more
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service